A recent study presented at the European Congress on Obesity (ECO) 2025 suggests that individuals diagnosed with new-onset type 2 diabetes may face an increased risk of developing obesity-related cancers. This finding adds to a growing body of research investigating the relationship between type 2 diabetes and cancer.
Study Overview
While previous studies have indicated a correlation between type 2 diabetes and an elevated risk of certain cancers, the causal nature of this connection remains unclear. Factors such as confounding variables, biases in study designs, and simultaneous diagnoses of diabetes and cancer have complicated the interpretation of these results. To address these issues, a new study using UK Biobank data aimed to clarify the relationship by investigating how newly diagnosed type 2 diabetes influences cancer risk.
Methodology and Key Findings
The study analyzed data from 23,750 individuals with new-onset type 2 diabetes, identified by the first recorded instance of non-insulin-dependent diabetes, and compared them with 71,123 matched controls based on body mass index (BMI), age, and sex. The primary focus was on obesity-related cancers, which include cancers of the liver, pancreas, colorectal, postmenopausal breast, endometrial, renal, esophageal, gastric, gallbladder, thyroid, meningioma, and ovarian.
Through statistical modeling and adjusting for factors like alcohol consumption, smoking, and the potential bias introduced by increased medical surveillance following a diabetes diagnosis, the researchers found that new-onset type 2 diabetes was associated with an increased risk of obesity-related cancers. After a median follow-up of five years, the study observed 2,431 new primary cancers in those with type 2 diabetes compared to 5,184 in the control group.
Specifically, the risk of obesity-related cancers was elevated by 48% in male patients and 24% in female patients with new-onset diabetes. This increase in risk was independent of BMI. However, the study found no significant associations between diabetes and certain cancers, such as endometrial and postmenopausal breast cancers.
Further analysis showed that the risk of colorectal cancer increased by 27% in men and 34% in women with new-onset diabetes. Pancreatic cancer risk was 74% higher in men and nearly doubled in women with the condition. For liver cancer, the risk was nearly four times higher in men and five times higher in women.
Conclusion and Future Research
The authors emphasized that the observed differences in cancer risk between male and female patients could be attributed to factors such as hormone levels, insulin sensitivity, body fat composition, or even the chance variance in the number of cancers detected in the UK Biobank.
The study’s findings highlight the need for further investigation into the mechanisms linking type 2 diabetes to cancer. Potential pathways under examination include hyperinsulinemia, hyperglycemia, and chronic inflammation. Of these, hyperinsulinemia—due to its role in stimulating cell growth and proliferation—emerges as the most plausible mechanism linking diabetes with an increased cancer risk.
Further research is needed to better understand the underlying biological processes and to determine whether these findings can guide future preventive strategies for patients with new-onset type 2 diabetes.
Related topics:
GLP-1 Agonists Show Promise for Kidney Transplant Patients with Type 2 Diabetes
Sleep Health Linked to Increased Type 2 Diabetes Risk in Women with Gestational Diabetes
